data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Compugen
(NASDAQ:CGEN)
2.09
-0.01[-0.48%]
At close: Jun 24
2.09
00
After Hours: 5:17PM EDT
Day High/Low1.97 - 2.17
52 Week High/Low1.55 - 9.2
Open / Close2.13 / 2.09
Float / Outstanding74.3M / 86.5M
Vol / Avg.703.5K / 908.7K
Mkt Cap180.7M
P/E-
50d Avg. Price2.02
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float74.3M

Compugen (NASDAQ:CGEN), Quotes and News Summary

Compugen (NASDAQ: CGEN)

Day High/Low1.97 - 2.17
52 Week High/Low1.55 - 9.2
Open / Close2.13 / 2.09
Float / Outstanding74.3M / 86.5M
Vol / Avg.703.5K / 908.7K
Mkt Cap180.7M
P/E-
50d Avg. Price2.02
Div / Yield-
Payout Ratio-
EPS-0.11
Total Float74.3M
Benzinga - May 16, 2022, 7:19AM
Benzinga - May 16, 2022, 6:47AM
Benzinga - Mar 21, 2022, 7:05AM
Benzinga - Mar 9, 2022, 7:26AM
Benzinga - Mar 9, 2022, 7:11AM
Benzinga - Feb 25, 2022, 8:46AM
Benzinga - Feb 25, 2022, 8:02AM
Benzinga - Feb 24, 2022, 7:47AM
Benzinga - Jan 18, 2022, 7:05AM
Benzinga - Dec 9, 2021, 7:14AM
Benzinga - Nov 12, 2021, 10:43AM
Benzinga - Nov 12, 2021, 7:08AM
Benzinga - Nov 12, 2021, 7:01AM
Benzinga - Nov 11, 2021, 7:41AM
load more
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its innovative immuno-oncology pipeline consists of four clinical stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-27
REV
Q1 2022Est.ActualSurprise
EPS-0.130-0.110 0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Compugen Questions & Answers

Q
How do I buy Compugen (CGEN) stock?
A

You can purchase shares of Compugen (NASDAQ: CGEN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Compugen's (CGEN) competitors?
A

There are no as such competitors for Compugen.

Q
What is the target price for Compugen (CGEN) stock?
A

The latest price target for Compugen (NASDAQ: CGEN) was reported by Oppenheimer on Friday, February 25, 2022. The analyst firm set a price target for 14.00 expecting CGEN to rise to within 12 months (a possible 569.86% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Compugen (CGEN)?
A

The stock price for Compugen (NASDAQ: CGEN) is $2.09 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Compugen (CGEN) pay a dividend?
A

There are no upcoming dividends for Compugen.

Q
When is Compugen (NASDAQ:CGEN) reporting earnings?
A

Compugen’s Q2 earnings are confirmed for Wednesday, July 27, 2022.

Q
Is Compugen (CGEN) going to split?
A

There is no upcoming split for Compugen.

Q
What sector and industry does Compugen (CGEN) operate in?
A

Compugen is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.